Akhlaghi Ali Asghar, Najafi Iraj, Mahmoodi Mahmood, Shojaee Abbas, Yousefifard Mahmoud, Hosseini Mostafa
Department of Epidemiology and Biostatistics, School of Public Health, Tehran University of Medical Science, Tehran, Iran.
J Res Health Sci. 2013 May 29;13(1):32-6.
Peritoneal dialysis is one of the most prevalent types of dialysis prescribed to the patients suffering from renal failure. Studies on the factors affecting the survival of these patients have mainly used log-rank test and Cox analysis. The present study aimed to investigate the risk factors affecting short- and long term survival of patients on continuous ambulatory peritoneal dialysis (CAPD) using cure model.
The data obtained retrospectively from 20 medical centers in Iran, between 1996 and 2009. All patients with renal failure who had been treated by CAPD and followed at least 3 months were included in the study. The STATA (11.0) software and CUREREGR module were used for survival analysis using cure model.
Totally 2006 patients were included in this study. The major reasons for renal failure were hypertension (35.4%) and diabetes (33.6%). The median of survival time was 4.8 years with a 95% confidence interval of 4.3 to 5.6 years. The percentage of long-lived patients surviving was 40% (95% CI: 32%, 47%). The analysis showed that the effect of diabetes, serum albumin level, age, diastolic blood pressure, and medical center was significant on the long-term survival of the patients. In addition, in short-term survival the effects of age, albumin, and medical center were significant.
By improving the quality of medical care in centers, nutritional status, controlling co-morbidities can help the patients on CAPD with better health and increase their short and long term survival.
腹膜透析是为肾衰竭患者开出的最常见的透析类型之一。关于影响这些患者生存的因素的研究主要使用对数秩检验和Cox分析。本研究旨在使用治愈模型调查影响持续性非卧床腹膜透析(CAPD)患者短期和长期生存的危险因素。
数据于1996年至2009年从伊朗的20个医疗中心回顾性获得。所有接受CAPD治疗并随访至少3个月的肾衰竭患者均纳入本研究。使用STATA(11.0)软件和CUREREGR模块通过治愈模型进行生存分析。
本研究共纳入2006例患者。肾衰竭的主要原因是高血压(35.4%)和糖尿病(33.6%)。生存时间中位数为4.8年,95%置信区间为4.3至5.6年。长期存活患者的比例为40%(95%CI:32%,47%)。分析表明,糖尿病、血清白蛋白水平、年龄、舒张压和医疗中心对患者的长期生存有显著影响。此外,在短期生存中,年龄、白蛋白和医疗中心的影响显著。
通过提高中心的医疗质量、营养状况、控制合并症,可以帮助CAPD患者保持更好的健康状态,提高他们的短期和长期生存率。